ATE539761T1 - Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion - Google Patents

Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion

Info

Publication number
ATE539761T1
ATE539761T1 AT07767796T AT07767796T ATE539761T1 AT E539761 T1 ATE539761 T1 AT E539761T1 AT 07767796 T AT07767796 T AT 07767796T AT 07767796 T AT07767796 T AT 07767796T AT E539761 T1 ATE539761 T1 AT E539761T1
Authority
AT
Austria
Prior art keywords
agent
injection
solution
wap
composition
Prior art date
Application number
AT07767796T
Other languages
English (en)
Inventor
Hirofumi Nakajima
Haruhiko Machida
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE539761T1 publication Critical patent/ATE539761T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07767796T 2006-06-29 2007-06-28 Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion ATE539761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006179778 2006-06-29
PCT/JP2007/063003 WO2008001849A1 (fr) 2006-06-29 2007-06-28 Agent destiné à être utilisé pour une injection comprenant un antibiotique et solution pour injection comprenant l'agent

Publications (1)

Publication Number Publication Date
ATE539761T1 true ATE539761T1 (de) 2012-01-15

Family

ID=38845613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07767796T ATE539761T1 (de) 2006-06-29 2007-06-28 Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion

Country Status (17)

Country Link
US (1) US7968588B2 (de)
EP (1) EP2047857B1 (de)
JP (1) JP5272126B2 (de)
KR (1) KR101286038B1 (de)
CN (1) CN101578103B (de)
AT (1) ATE539761T1 (de)
AU (1) AU2007266063B2 (de)
BR (1) BRPI0713080A2 (de)
CA (1) CA2656604C (de)
DK (1) DK2047857T3 (de)
ES (1) ES2378279T3 (de)
MX (1) MX2009000155A (de)
PL (1) PL2047857T3 (de)
PT (1) PT2047857E (de)
RU (1) RU2462261C2 (de)
SI (1) SI2047857T1 (de)
WO (1) WO2008001849A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101931880A (zh) 2009-06-19 2010-12-29 中兴通讯股份有限公司 一种多媒体广播组播业务动态复用的资源分配方法
JP5878302B2 (ja) * 2010-05-25 2016-03-08 株式会社ゲノム創薬研究所 新規環状ペプチド化合物とその製造方法及び感染症治療薬
JP5878303B2 (ja) * 2010-05-25 2016-03-08 株式会社ゲノム創薬研究所 抗生物質含有画分、その抗生物質及びその抗生物質の製造方法
MX2019006939A (es) * 2016-12-14 2019-09-13 Sk Biopharmaceuticals Co Ltd Preparacion liquida parenteral que comprende compuesto de carbamato.
US10975121B2 (en) 2017-06-24 2021-04-13 Cytogel Pharma, Llc Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
ES2969958T3 (es) * 2017-11-30 2024-05-23 Cytogel Pharma Llc Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas
KR102434276B1 (ko) 2017-12-08 2022-08-18 엘지디스플레이 주식회사 표시장치
CA3103390A1 (en) * 2018-06-13 2019-12-19 Kyoto Biopharmaceuticals, Inc. Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3339235B2 (ja) 1994-02-18 2002-10-28 日本メディカルリサーチ株式会社 抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤
HU218351B (hu) * 1995-02-02 2000-08-28 Nippon Medical Research, Inc. WAP-8294A antibiotikumok, eljárás előállításukra, a termelő mikroorganizmus és az antibiotikumokat tartalmazó antibakteriális gyógyszerkészítmények
EP0838225A3 (de) 1996-10-25 1999-03-24 Hiji, Yasutake Wässrige Lösung eines Lokalanästheticum
JP4270588B2 (ja) 1996-11-14 2009-06-03 康武 日地 神経毒軽減麻酔剤
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
MXPA01010247A (es) * 1999-04-15 2002-03-27 Lilly Co Eli Composiciones antifungosas de pseudomicina y metodos para su uso.
CA2375829A1 (en) 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
JP4074457B2 (ja) 2001-12-20 2008-04-09 田辺三菱製薬株式会社 ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
MXPA04009037A (es) 2002-03-20 2005-01-25 Pharmacia Corp Formulacion de eplerenona de almacenamiento estable.
AUPS188302A0 (en) 2002-04-22 2002-05-30 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
JP2003321364A (ja) * 2002-05-07 2003-11-11 Eisai Co Ltd シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物
EP1504755A1 (de) 2002-05-13 2005-02-09 Daiichi Pharmaceutical Co., Ltd. Lyophilisiertes produkt
DE10228049A1 (de) * 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
US7361683B2 (en) 2004-11-24 2008-04-22 Yung Shin Pharm. Ind., Co., Ltd Paclitaxel aqueous injection solution and methods for preparing the same

Also Published As

Publication number Publication date
WO2008001849A1 (fr) 2008-01-03
CA2656604C (en) 2014-01-07
EP2047857A4 (de) 2010-05-26
PT2047857E (pt) 2012-03-15
RU2009102803A (ru) 2010-08-10
MX2009000155A (es) 2009-03-25
SI2047857T1 (sl) 2012-03-30
JPWO2008001849A1 (ja) 2009-11-26
KR20090030317A (ko) 2009-03-24
EP2047857B1 (de) 2012-01-04
JP5272126B2 (ja) 2013-08-28
AU2007266063A1 (en) 2008-01-03
RU2462261C2 (ru) 2012-09-27
ES2378279T3 (es) 2012-04-10
US20090258920A1 (en) 2009-10-15
PL2047857T3 (pl) 2012-05-31
BRPI0713080A2 (pt) 2012-10-09
KR101286038B1 (ko) 2013-07-19
EP2047857A1 (de) 2009-04-15
DK2047857T3 (da) 2012-02-27
CA2656604A1 (en) 2008-01-03
CN101578103A (zh) 2009-11-11
CN101578103B (zh) 2013-09-25
AU2007266063B2 (en) 2011-09-08
US7968588B2 (en) 2011-06-28

Similar Documents

Publication Publication Date Title
ATE539761T1 (de) Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion
CN101242824B (zh) 乙酰半胱氨酸组合物及其应用
EA200700389A1 (ru) Стабильный при хранении инфузионный раствор дигидроптеридинонов
ATE430564T1 (de) Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
SI2640358T1 (en) Continuous administration of L-dopa, dopamine decarboxylase inhibitors, catechol-O-methyl transferase inhibitors, and compositions thereof
ECSP066477A (es) Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
IL291556B2 (en) Methods and compositions for administration of arylsulfatase A to the central nervous system
WO2009097443A3 (en) Liquid formulations of compounds active at sulfonylurea receptors
DE60116483D1 (de) Gelartige pharmazeutische zusammensetzung zur subcutanen anwendung enthaltend bisphosphonsäuren oder deren salze
BRPI0418474A (pt) solução aquosa parenteral estável
WO2007056263A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
ATE493143T1 (de) Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
CL2008001332A1 (es) Uso de temozolomida para preparar un medicamento util para el tratamiento de un desorden proliferativo.
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
NO20061458L (no) Infusjonspreparat inneholdende (2R)-2-propyloktansyre som den aktive bestanddel
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
JPH075456B2 (ja) 点眼液
BRPI0815280A2 (pt) medicamento que compreende uma formulação líquida aquosa de g-csf, receptáculo para a administração de medicamentos líquidos, seringa ou ampola, kit para a administração parenteral de g-csf
TWI410250B (zh) 以榖胱甘肽作為氫氧化四甲基銨之解毒劑
BRPI0415574A (pt) composto, nanopartìcula, associação de uma nanopartìcula com um composto e composição terapêutica, de diagnóstico, de vacina ou cosmética
PT1683518E (pt) Formulação farmacêutica de formoterol e propilenoglicol
GR20110100037A (el) Τοπικο αναισθητικο